Portfolios rarely get designed this way. They accumulate: opportunistic deals, local decisions, and legacy renewals layered on top of each other. As scrutiny increases, finance pushes for ROI clarity and procurement pushes for discipline, and you’re left trying to answer a basic question:
Is this portfolio actually healthy?
You don’t need a six-month project to get a first answer. You can learn a lot by looking for a handful of simple warning signs that we see show up again and again in underperforming sponsorship portfolios.
If three or more of these feel uncomfortably familiar, it’s a strong signal that you’re leaving value on the table and that it’s time to rethink how your portfolio is built and managed.
1. You can’t clearly state what each property is for
In a healthy portfolio, every property has a clear, deliberately chosen primary job.
Great sponsorships can deliver against multiple objectives, such as penetration, pricing power, acquisition, or channel support, but one needs to be primary.
A quick test: pick three of your bigger properties and ask three different people on your team what each one is for. If you get three different answers, you don’t have clarity, you have stories.
When the role of a property isn’t clear:
- Activation teams default to generic, safe ideas.
- Internal stakeholders pull the property in different directions.
- It becomes hard to decide what to cut, protect, or grow.
What to do next:
Force yourself to write a one sentence “job to be done” for every property. One primary job, not a list. If you can’t do that, or if the job doesn’t align with real business priorities, that property is a candidate to be repurposed, repositioned or exited.
2. Your anchor properties don’t carry the portfolio
Healthy portfolios are intentionally skewed.
A small number of anchor platforms in a given market should carry a disproportionate share of the value, attention, and activation effort. Unhealthy portfolios often look flat: a long list of priorities where everything is important, and nothing truly is.
A simple check:
- Which properties are genuinely capable of driving penetration, preference, or commercial impact?
- How much budget, time, and talent are you putting against those versus everything else?
If your strongest properties don’t function as clear anchors, or if they’re underfunded relative to the long tail, that’s a warning sign.
What to do next:
Classify each property into anchor, supporting, and experimental. Then align budget, activation, and internal focus accordingly. If they don’t match, shift energy from the long tail into your true anchors.
3. Legacy and passion buys crowd out strategic choices
Most portfolios carry legacy deals and properties selected because someone internally wants them.
The issue isn’t their existence. It’s what they displace.
You’ll know this is happening if:
- You spend time defending historic or politically sensitive deals.
- Renewal decisions are driven by habit or senior preference rather than performance and fit.
- You regularly hear “we could never drop that” without a current rationale.
In that environment, internal dynamics start to steer capital allocation more than strategy does.
What to do next:
Introduce a standard review cadence where every deal has to re earn its place against current strategy. You may still keep some of these properties, but you’ll be making a conscious trade-off.
4. You’re over-invested in rights relative to activation
Rights are only as valuable as your ability to activate them well.
One of the most common warning signs is a chronic imbalance between rights fees and activation investment. Across global portfolios, activation typically trails rights (around 0.8:1). Programs that approach parity are far more likely to break through.
You’ll see this when:
- A disproportionate share of the budget is tied up in rights, leaving limited funds for activation.
- Activation is consistently generic or last minute.
- Teams regularly say “we never really took advantage of that partnership this year/season/round.”
When rights outpace activation, you’re paying for value you never fully realize.
What to do next:
Set a target activation to rights ratio, by market and by property type, and assess where you actually land. For properties that can’t be activated effectively within that range, reduce scope, renegotiate, or exit. It’s better to do fewer things properly than to own more rights than you can use.
5. There’s no single decision framework across markets and brands/business units
Many portfolios are built deal by deal, with different people using different criteria.
The result is inconsistent decisions, weak comparability, and inefficient capital allocation.
You may recognize this if:
- Each market or business unit applies its own criteria.
- It’s difficult to compare two properties side by side.
- The long tail of sponsorships is hard to challenge.
Without a shared framework, optimization at scale is almost impossible.
What to do next:
Define a simple, shared decision framework built on non-negotiables, trade-offs, and exclusion criteria. Use it for both new deals and renewals. This creates a common language and raises the bar for what gets into the portfolio.
6. You rely on media equivalencies as your primary valuation tool
A proper valuation answers one question: does the rights fee reflect fair market value for the category rights you hold?
Impressions and media equivalencies are inputs, not valuations. If you’re not separating tangible and intangible value, you’re not valuing the deal.
Using media equivalencies as your primary tool collapses sponsorship into an advertising proxy. It ignores IP rights, associative benefits, and how sponsorship is actually priced in market, where value is set by comparable rights, not by your media schedule.
What to do next:
Keep media value as a benchmarking input, but move it into its proper place. Use a valuation approach that distinguishes between tangible and intangible asset value, then compare that combined value to the rights fee to determine whether you are paying fair market value.
7. The portfolio reflects yesterday’s strategy, not the strategy you have now
Your portfolio can be full of individually successful properties that are collectively misaligned with how the business needs to perform today.
This shows up when:
- Properties align to past priorities, not current growth or defend priorities.
- Investment is weighted toward markets, audiences, or channels that are no longer critical.
- New strategic priorities struggle to find a clear role in the portfolio.
In other words, the portfolio reflects an older version of the business.
What to do next:
Map your portfolio against three lenses: where you need to grow, where you need to defend, and where you can afford to harvest. For each property, assess whether it supports one of those lenses, can be evolved to do so, or is fundamentally misaligned.
From Diagnosis To Discipline
If three or more of these are present, the issue is not diagnosis. The question is how disciplined you want to be about fixing it.
A healthy portfolio is not just a better set of properties. It is a set of clear guardrails around how you buy, structure, and manage them. This is the work the Sponsorship Portfolio Health Check™ is designed to do.
At its core, the Health Check establishes clear guardrails:
- Activation to rights fee ratios by property type and market, preventing chronic over-buying relative to activation capacity.
- Rights fee to value ratios based on proper valuation of tangible and intangible assets, ensuring you are paying fair market value.
- Clear guidance on asset packages, so you are not paying for assets you rarely use.
- Guidance on when to use fixed versus performance-linked deal structures.
You do not need to apply this level of rigour to every deal. In most cases, focusing on the top 70 to 80 per cent of spend is enough to reshape the portfolio.
Within that scope, the Health Check provides a clear view of:
- What to keep and protect.
- What to fix, reshape, or repurpose.
- What to exit, so you can reinvest in fewer, bigger, better platforms.
The output is a prioritized roadmap for how the portfolio should evolve over the next 12–24 months, grounded in current business strategy.
If you want a clear view of where your portfolio stands and the first moves to prioritize, book a short diagnostic conversation with our team.
